Marshall Wace, LLP Tiziana Life Sciences LTD Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Marshall Wace, LLP holds 268,012 shares of TLSA stock, worth $455,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
268,012
Previous 24,369
999.81%
Holding current value
$455,620
Previous $38,000
1394.74%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.06MCall Options Held
32KPut Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI2.74MShares$4.65 Million4.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny241KShares$409,3830.0% of portfolio
-
Morgan Stanley New York, NY97.1KShares$165,0730.0% of portfolio
-
Zhang Financial LLC84.2KShares$143,1400.01% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$134,9200.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $174M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...